25 años después del estreno de Philadelphia (1993)¿Qué cosas han cambiado en la infección por VIH?

  1. PINTOR HOLGUÍN, Emilio 1
  2. HERREROS RUIZ-VALDEPEÑAS, Benjamín 1
  3. GARGANTILLA MADERA, Pedro 1
  4. GUTIÉRREZ CISNEROS, María Josefa 1
  1. 1 Universidad Europea de Madrid
    info

    Universidad Europea de Madrid

    Madrid, España

    ROR https://ror.org/04dp46240

Revista:
Revista de medicina y cine

ISSN: 1885-5210

Any de publicació: 2020

Volum: 16

Número: 1

Pàgines: 37-42

Tipus: Article

DOI: 10.14201/RMC20201613742 DIALNET GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Revista de medicina y cine

Resum

In present year 2019, 25 years of the premiere of the film Philadelhia by Jonathan Demme have been fulfilled, which in our country took place in March 1994. With this paper, we try to make a reflection of the changes that have occurred in HIV infection in diagnosis, treatment and prognosis as well as in the social field: when the film was presented about 10 years later first patients were diagnosed, HIV infection was considered as a disease with widespread social rejection with stigmatization of several risk groups (homosexuals, intravenous drug users and hemophiliacs) and ways of transmission, diagnosis was usually made in late stages of the disease with severe immunodeficiency symptoms such as Kaposi’s sarcoma, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and cryptococcal meningitis and the treatments were ineffective. At present, diagnosis and treatment is much earlier and more effective and social stigmatization has disappeared.

Referències bibliogràfiques

  • Aijon Oliva J. Philadelphia (1993): las claves de un icono cultural. Rev Med Cine [internet] 2005;1(4):109-14.
  • Área de vigilancia de VIH y conductas de riesgo. Mortalidad por VIH y sida en España, año 2016. Evolución 1981-2016. Madrid: Centro Nacional de Epidemiología/ Subdirección General de Promoción de la Salud y Vigilancia en Salud Pública- Plan Nacional sobre el Sida; 2018.
  • Área de Vigilancia de VIH y Comportamientos de Riesgo. Vigilancia Epidemiológica del VIH y sida en España 2017: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Madrid: Plan Nacional sobre el Sida - D.G. de Salud Pública, Calidad e Innovación / Centro Nacional de Epidemiología - ISCIII.2018.
  • European AIDS Clinical Society (EACS). Guía Clínica Versión 9 Octubre de 2017. Eur AIDS Clin Soc. 2017.
  • Franceschi S, Maso LD, Rickenbach M, Polesel J, Hirschel B, Cavassini M, et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer. 2008;99(5):800-4. https://doi.org/10.1038/sj.bjc.6604520
  • Fuster-RuizdeApodaca MJ, Molero F, Gil de Montes L, Agirrezabal A, Toledo J, Jaen A, Spanish Group for the Study of HIV-Related Stigma. Evolution of HIV-related stigma in Spain between 2008 and 2012. AIDS Care. 2014;26(SUPPL. 1):41-5. https://doi.org/10.1080/09540121.2014.906557
  • Greene WC. A history of AIDS: Looking back to see ahead. Eur J Immunol. 2007;37 (1):S94-102. https://doi.org/10.1002/eji.200737441
  • Holliday AC, Wagner Jr RF. Kaposi's Sarcoma in Film. Rev Med Cine [Internet]. 2013;9(3):107-13.
  • Johnson SC, MD. Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy. Top Antivir Med. 2015;23(5):161-7.
  • Lozano F, Domingo P. Tratamiento antirretroviral de la infección por el VIH. Enferm Infecc Microbiol Clin. 2011;29(6):455-65. https://doi.org/10.1016/j.eimc.2011.02.009
  • Masur H. Recurring and emerging questions related to management of HIVrelated opportunistic infections. Top Antivir Med. 2018;26(3):79-84.
  • Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, et al. Cancer incidence in the multicenter aids cohort study before and during the HAART era: 1984 to 2007. Cancer. 2010;116(23):5507-16. https://doi.org/10.1002/cncr.25530
  • Perez-Hoyos S, Rodríguez-Arenas MÁ, de la Hera MG, Iribarren JA, Moreno S, Viciana P, et al. Progression to AIDS and Death and Response to HAART in Men and Women from a Multicenter Hospital-Based Cohort. J Women's Heal. 2007;16(7):1052-61. https://doi.org/10.1089/jwh.2007.0437
  • Perez Ochoa L. Philadelphia (1993): Visión del SIDA cuando comenzó a ser tratable. Rev Med Cine [internet] 2006;2(1):109-14.
  • Pintor E, Vivas-Rojo E, Herreros B, Gargantilla P. La vida alegre (1987): la importancia del preservativo para prevenir las ETS. Rev Med Cine [internet] 2015; 11(3): 157-62.
  • Unidad de vigilancia del VIH y conductas de riesgo. Vigilancia epidemiológica de las infecciones de transmisión sexual, 2016. Madrid: Centro Nacional de Epidemiología/Subdirección General de Promoción de la Salud y Vigilancia en Salud Pública - Plan Nacional sobre el Sida; 2018.
  • Wolff MJ, Giganti MJ, Cortes CP, Cahn P, Grinsztejn B, Pape JW, et al. A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy. PLoS One. 2017;12(6):e0179769. https://doi.org/10.1371/journal.pone.0179769
  • Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med 2018;378(11):1029-41. https://doi.org/10.1056/NEJMra1615896
Fuente de los datos: Dialnet